A method for early evaluation of a recently introduced technology by deriving a comparative group from existing clinical data: A case study in external support of the Marfan aortic root

BMJ Open

Volumn 2, Issue 2, 2012, Pages

  Treasure, Tom ^a   Crowe, Sonya ^a   John Chan, K M ^b   Ranasinghe, Aaron ^c,d   Attia, Rizwan ^e   Lees, Belinda ^b   Utley, Martin ^a   Golesworthy, Tal ^f   Pepper, John ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f Exstent Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA;

ADOLESCENT; ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; ASCENDING AORTA; BLEEDING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; MALE; MARFAN SYNDROME; MESH SLING; THROMBOCYTE TRANSFUSION; UNITED KINGDOM;

EID: 84860208917     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000725     Document Type: Article

References (41)

1. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009;374:1105-12.
2. Evans I, Thornton H, Chalmers I, et al. Testing Treatments. 2nd edn. London: Pinter & Martin, 2011.
3. Cooper JD. Randomized clinical trials for new surgical operations: square peg in a round hole? J Thorac Cardiovasc Surg 2010;140:743-6.
4. Treasure T, Utley M. Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133:1414-18. (Pubitemid 46805160)
5. Morton D, Treasure T. GRIST: growing recruitment into interventional and surgical trials. JRSM 2012. In press.
6. Murdoch JL, Walker BA, Halpern BL, et al. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972;286:804-8.
7. Januzzi JL, Marayati F, Mehta RH, et al. Comparison of aortic dissection in patients with and without Marfan's syndrome (results from the International Registry of Aortic Dissection). Am J Cardiol 2004;94:400-2. (Pubitemid 38962720)
8. Ranasinghe A, Strong D, Bonser R. Easily missed? Aortic dissection. Br Med J 2011;343:317-19.
9. Pepper J, Golesworthy T, Utley M, et al. Manufacturing and placing a bespoke support for the Marfan aortic root: description of the method and technical results and status at one year for the first ten patients. Interact Cardiovasc Thorac Surg 2010;10:360-5.
10. National Institute for Health and Clinical Excellence (NICE). Understanding NICE Guidance: Information for People Who Use NHS Services, Fitting an External Stent to Support the Aorta in Patients with Marfan Syndrome. National Institute for Health and Clinical Excellence (NICE), 2011. http://guidance.nice.org.uk/IPG394
11. Treasure T, Pepper JR. Aortic root surgery in Marfan syndrome. Heart 2011;97:951-2.
12. Treasure T. The evolution of aortic root surgery for Marfan syndrome. Interact Cardiovasc Thorac Surg 2010;10:353-5.
13. Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995;75:157-60.
14. Treasure T. Cardiovascular surgery for Marfan syndrome. Heart 2000;84:674-8.
15. Kirsch ME, Ooka T, Zannis K, et al. Bioprosthetic replacement of the ascending thoracic aorta: what are the options? Eur J Cardiothorac Surg 2009;35:77-82.
16. Yacoub MH, Gehle P, Chandrasekaran V, et al. Late results of a valvepreserving operation in patients with aneurysms of the ascending aorta and root. J Thorac Cardiovasc Surg 1998;115:1080-90. (Pubitemid 28224403)
17. David TE, Armstrong S, Ivanov J, et al. Results of aortic valve-sparing operations. J Thorac Cardiovasc Surg 2001;122:39-46.
18. Benedetto U, Melina G, Takkenberg JJ, et al. Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis. Heart 2011;97:955-8.
19. Treasure W. Diagnosis and Risk Management in Primary Care: Words that Count, Numbers that Speak. London: Radcliffe Publishing, 2011.
20. Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005;366:1965-76. (Pubitemid 41713988)
21. Pepper J, John CK, Gavino J, et al. External aortic root support for Marfan syndrome: early clinical results in the first 20 recipients with a bespoke implant. J R Soc Med 2010;103:370-5.
22. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974;15:443-53.
23. Taves DR. The use of minimization in clinical trials. Contemp Clin Trials 2010;31:180-4.
24. Treasure T, Farewell V. Minimization in interventional trials: great value but residual vulnerability. J Clin Epidemiol 2012;65:7-9.
25. Devereaux PJ, Bhandari M, Clarke M, et al. Need for expertise based randomised controlled trials. BMJ 2005;330:88.
26. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. (Pubitemid 351665487)
27. Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ 1995;311:1621-5. (Pubitemid 26002712)
28. Treasure T, Hasan A, Yacoub M. Is there a risk in avoiding risk for younger patients with aortic valve disease? BMJ 2011;342:d2466.
29. Golesworthy T, Lampérth M, Mohiaddin R, et al. The Tailor of Gloucester: a jacket for the Marfan's aorta. Lancet 2004;364:1582. (Pubitemid 39446379)
30. Treasure T, Pepper J, Golesworthy T, et al. Eternal aortic root support: NICE guidance. Heart 2012;98:65-8.
31. Murgatroyd F, Child A, Poloniecki J, et al. Does routine echocardiographic measurement of the aortic root diameter predict the risk of aortic dissection in the Marfan syndrome. Eur Heart J 1991;12:410.
32. Murgatroyd F, Child A, Poloniecki J, et al. Echocardiographic and clinical features are inadequate guides to the management of patients with the Marfan syndrome. Br Heart J 1993;68:84-5.
33. Robicsek F, Thubrikar MJ. Conservative operation in the management of annular dilatation and ascending aortic aneurysm. Ann Thorac Surg 1994;57:1672-4. (Pubitemid 24216355)
34. Robicsek F, Thubrikar M. The mechanism and prevention of aortic dissection in Marfan Syndrome. In: Hetzer R, Gehke P, Ennker J, eds. Cardiovascular Aspects of Marfan Syndrome. Darmstadt: Steinkopff, 1995:61-70.
35. Treasure T. The Safe Duration of Total Circulatory Arrest with Profound Hypothermia. Thesis: University of London, 1982.
36. Treasure T, Naftel DC, Conger KA, et al. The effect of hypothermic circulatory arrest time on cerebral function, morphology, and biochemistry. An experimental study. J Thorac Cardiovasc Surg 1983;86:761-70. (Pubitemid 14228803)
37. Treasure T. The safe duration of total circulatory arrest with profound hypothermia. Ann R Coll Surg Engl 1984;66:235-40. (Pubitemid 14121035)
38. Pye D. The Nature and Art of Workmanship. Huntingdon, UK: Cambridge University Press, 1968.
39. Treasure T, Golesworthy T, Pepper J, et al. Prophylactic surgery of the aortic root in Marfan Syndrome: reconsideration of the decision making process in the era of customised external aortic root support. J Vasc Endovasc Surg 2011;18:215-23.
40. Kim SY, Martin N, Hsia EC, et al. Management of aortic disease in Marfan Syndrome: a decision analysis. Arch Intern Med 2005;165:749-55. (Pubitemid 40569427)
41. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax 1968;23:338-9.